Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol...
Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
About this item
Full title
Author / Creator
Cestario, Elizabeth do Espirito Santo , Vilela-Martin, Jose Fernando , Cosenso-Martin, Luciana Neves , Rubio, Tatiane Azevedo , Uyemura, Jessica Rodrigues Roma , da Silva Lopes, Valquiria , Fernandes, Letícia Aparecida Barufi , Bonalume Tacito, Lucia Helena , Moreno Junior, Heitor and Yugar-Toledo, Juan Carlos
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Hypertension is the most important modifiable risk factor for cardiovascular disease and a leading public health concern.
The primary aim was to compare sequential nephron blockade (SNB) versus dual renin-angiotensin system blockade (DRASB) plus bisoprolol in patients with resistant hypertension to observe reductions in systolic and diastolic bl...
Alternative Titles
Full title
Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_48cac253a1b443739372328559adf680
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_48cac253a1b443739372328559adf680
Other Identifiers
ISSN
1178-2048,1176-6344
E-ISSN
1178-2048
DOI
10.2147/VHRM.S383007
